Utah Retirement Systems’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,900
Closed -$1.19M 980
2022
Q3
$1.19M Buy
+7,900
New +$1.17M 0.02% 640

Other funds holding BHVN

Utah Retirement Systems's BHVN Position: Q4 2022 in Review

Utah Retirement Systems sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 7,900 shares — an estimated $1.19M sold.

Utah Retirement Systems first reported a position in BHVN in Q3 2022 and held it in 1 quarter. The position peaked at $1.19M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Utah Retirement Systems reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Utah Retirement Systems sold 7,900 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $1.19M.
  • Utah Retirement Systems first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022 and held it in 1 quarter.
  • Utah Retirement Systems's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $1.19M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Utah Retirement Systems's 13F filing for Q4 2022, filed 15 Feb 2023.